Osteocare (Tablets, Solution) Instructions for Use

ATC Code

M05BX (Other drugs affecting bone structure and mineralization)

Clinical-Pharmacological Group

Drug regulating calcium and phosphorus metabolism

Pharmacotherapeutic Group

Calcium-phosphorus metabolism regulator

Pharmacological Action

A combined drug that replenishes the deficiency of calcium, magnesium, zinc, and vitamin D; regulates phosphorus-calcium metabolism.

It accelerates the mineralization of bone tissue and the formation of callus.

Calcium is involved in the formation of bone tissue, the transmission of nerve impulses, and is necessary for maintaining cardiac activity.

Magnesium is involved in the regulation of calcium metabolism, bone growth and mineralization; together with vitamin D, it maintains bone homeostasis.

Colecalciferol (vitamin D) regulates the metabolism of calcium and phosphorus, the process of building bone structure; increases the absorption of calcium ions in the intestine, protein synthesis in the small intestine, liver, and bones; and the excretion of phosphates by the kidneys.

It stimulates DNA synthesis in osteocytes, inhibits the function of osteoclasts, and slows down the processes of bone tissue involution.

Indications

Prevention of osteoporosis (including during menopause, in old age); disorders of calcium metabolism (including during pregnancy and lactation, convalescence); bone fractures (to accelerate healing); period of intensive growth in childhood and adolescence; active sports; dietary calcium deficiency.

ICD codes

Dosage Regimen

Tablets

Orally (before or during meals), without chewing, 1 tablet 2 times a day.

Solution

For adults and children over 6 years old, 1 teaspoon (5 ml) 2 times a day with meals. The duration of administration is 2-3 weeks.

This is not a medicine.

Contraindications

Individual intolerance to components, hypercalcemia, diabetes mellitus. It is recommended to consult a doctor before use.

Adverse Reactions

Allergic reactions.

Contraindications

Hypersensitivity; hypercalcemia.

Use in Pregnancy and Lactation

Used as indicated during pregnancy and lactation.

Pediatric Use

The drug is indicated for use during the period of intensive growth in childhood and adolescence.

Geriatric Use

The drug is approved for use in elderly patients.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.